KARAKTERISTIK PENDERITA DIABETES MELITUS TIPE 2 DENGAN COVID-19 DI RUMAH SAKIT UMUM Prof.Dr. I.G.N.G NGOERAH
Keywords:Complications, Covid-19, Diabetes Melitus
Introduction: COVID-19 is caused by a novel coronavirus known as SARS-CoV-2, a single chain RNA virus with a particle size of 120-160 nm. COVID-9 can affect almost all age groups, despite, the elderly and people who have records of chronic disease (co-morbid) have the risk to be affected more often and with worse complications from this disease. Type 2 Diabetes mellitus (DM) is one of the risk factors for enhancing the severity of COVID-19 infection
Method: This study is a descriptive study with cross-sectional approach. Sampling with consecutive sampling. This sampling was done from Januari 2021 until April 2021. Analysis done with SPSS application.
Results: From 57 patients, 54.4% was male vs 45.6.7% was female. 43.9% was above 60 years old vs 56.1% was below 60 years old. 17.1% with insulin regimen vs 82.9% oral diabetic drug. 60.4% with overweight BMI vs 39.4% normal BMI. 7% with below 6.5 Hba1c vs 93% above 6.5 Hba1c. 51.4% patients more than 5 years duration of diabetes vs 40% over 5 years and 8.6% over 10 years.1.8% patients with moderate COVID-19 vs 38.6% Severe COVID-19 vs 59.6% with Critical Ill COVID-19.
Conclusion: from this study, we can learn the characteristic Type 2 Diabetes Melitus patients with COVID-19. Factors like age, gender, A1c level, duration of diabetes, were associated with severity of COVID-19. However, this study has a lot of weakness from methods, analysis and sampel similarity. We hope that another study can be better method than this study.
Keywords: diabetes, covid 19 infection, complication
PERKENI. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia. (PB PERKENI, 2019).
Samya, V. et al. Prevalence of Hypoglycemia Among Patients With Type 2 Diabetes Mellitus in a Rural Health Center in South India. J. Prim. Care Community Health 10, 215013271988063 (2019).
Dubose, S. et al. 926-P: Frequency of Hypoglycemia by Gender in Healthy Individuals without Diabetes—Not So Different After All. Diabetes 68, 926-P (2019).
Fukuda, M., Doi, K., Sugawara, M., Naka, Y. & Mochizuki, K. Survey of Hypoglycemia in Elderly People With Type 2 Diabetes Mellitus in Japan. J. Clin. Med. Res. 7, 967–978 (2015).=
Biswas,M.Rahaman S.,Haque,Z.&Ibrahim,B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.Intervirology Karger.(2020)
Juan, A.L, Ariana, P.B.,Mayte,B.A. Diabetes increases the risk of COVID-19 in an altitude
dependent manner: An analysis of 1,280,806 Mexican patients.PLOS ONE, (2021)
Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N
Engl J Med. 2020;382(18):1708-1720. doi:10.1056/nejmoa2002032
N.L Praptika, K.WKarya. Peran HbA1c dalam progresi dan prognosis COVID-19 pada pasien
diabetes mellitus. http://dx.doi.org/10.15562/ism.v12i3.1113 2021
Sumanta, S. Rami,AR., Sujata S. Diabetes prevalence and mortality in COVID-19 patients: a
systematic review, meta‐analysis, and meta‐regression. Journal of Diabetes and Metabolic
Liu Y, Yan L-M, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet
Infect Dis. 2020;20:656–7. doi: 10.1016/S1473-3099(20)30232-2
Zhu, D. Zhang, W. Wang et al., “A novel coronavirus from patients with pneumonia in China,
,” New England Journal of Medicine, vol. 382, no. 8, pp. 727–733, 2020.
Z. Wu and J. M. McGoogan, “Characteristics of and im- portant lessons from the coronavirus
disease 2019 (COVID- 19) outbreak in China,” JAMA, vol. 323, no. 13, p. 1239, 2020.
B Li, J. YangF. Zhao et al., Prevalence and impact of car- diovascular metabolic diseases on
COVID-19 in China,” Clinical Research in Cardiology, vol. 109, no. 5, pp. 531–538, 2020.
J. Yang, Y. Zheng, X. Gou et al., “Prevalence of comorbidities and its effects in patients
infected with SARS-CoV-2: a sys- tematic review and meta-analysis,” International Journal of
Infectious Diseases, vol. 94, pp. 91–95, 2020.
L. Fang, G. Karakiulakis, and M. Roth, “Are patients with hypertension and diabetes mellitus
at increased risk for COVID-19 infection?” The Lancet Respiratory Medicine, vol. 8, no. 4, p.